Galectin Therapeutics Inc (NASDAQ:GALT)

4.06
Delayed Data
As of May 23
 -0.10 / -2.40%
Today’s Change
1.28
Today|||52-Week Range
6.74
+21.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses4.5M4.4M2.4M4.2M
 
 
 
 
 
Research And Development3.4M3.5M1.0M2.3M
 
 
 
 
 
Total Operating Expenses4.5M4.4M2.4M4.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.5M-4.4M-2.4M-4.2M
 
 
 
 
 
Interest Expense On Debt0.000.000.0084.0K
 
 
Other Expenses0.000.00-12.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.5M-4.4M-2.4M-4.3M
 
 
 
 
 
Preferred Dividend-301.0K-254.0K-405.0K-285.0K
 
 
 
 
 
Net Income-4.5M-4.4M-2.4M-4.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.7M35.2M35.8M37.3M
 
 
 
 
 
Shares To Calculate EPS Diluted34.7M35.2M35.8M37.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.14-$0.13-$0.07-$0.12
 
 
 
 
 
EPS Diluted-$0.14-$0.13-$0.08-$0.12